更新PRISMA网络元分析报告准则:一个范围审查
Areti Angeliki Veroniki1, Andrea C Tricco2, Daniella Rangira3
1Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, Ontario, Canada; Institute for Health Policy, Management, and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, Canada; Center for Evidence Synthesis in Health, Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
本范围审查确定了37个新的报告项目,以更新网络元分析 (NMA) 系统审查和元分析 (PRISMA) 推广的首选报告项目. 这些更新旨在提高NMA的透明度和可信度.
科学领域:
- 证据综合的方法论.
- 生物统计和流行病学研究.
背景情况:
- 网络元分析 (NMA) 的2015年系统审查和元分析优先报告项目 (PRISMA) 扩展需要更新.
- 现有的NMA报告准则需要提高可用性,完整性和透明度,以满足不同受众的需求.
研究的目的:
- 为更新PRISMA-NMA指南进行首次范围审查.
- 为了使更新的指南与PRISMA 2020标准保持一致.
- 解决国家管理局的关键报告缺陷,包括同质性,过渡性,干预定义和统计建模.
主要方法:
- 协议登记在开放科学框架,并发表在JBI证据综合.
- 在多个数据库和灰色文献中进行全面搜索.
- 重复选和数据提取,重点关注NMA报告建议.
主要成果:
- 61项研究符合资格标准 (23项指导文件,38项综述).
- 确定了37个与NMA相关的额外报告项目.
- 这些项目将为PRISMA-NMA更新的德尔菲共识进程提供信息.
结论:
- 迫切需要更新PRISMA-NMA指南.
- 解决报告缺陷和纳入方法进步至关重要.
- 更新将提高NMA的透明度,可复制性和可信度.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
相关概念视频
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Bias in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Statistical Methods for Analyzing Epidemiological Data
